Gastric Small Cell Carcinoma Successfully Treated by Surgery and Postoperative Chemotherapy Consisting of Cisplatin and S-1: Report of a Case
暂无分享,去创建一个
N. Koide | A. Suzuki | S. Miyagawa | Toshiyuki Sato | H. Ota | M. Murakami | H. Saito | Hiroyasu Saito
[1] K. Sugimachi,et al. The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: Report of a case , 2006, Surgery Today.
[2] A. Hussein,et al. Small cell carcinoma of the stomach , 1990, Digestive Diseases and Sciences.
[3] A. Kabashima,et al. Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer , 2004, Gastric Cancer.
[4] K. Muro,et al. Long-term survivor of gastric small cell carcinoma. , 2004, Hepato-gastroenterology.
[5] M. Kitajima,et al. Advanced gastric endocrine cell carcinoma with distant lymph node metastasis: a case report and clinicopathological characteristics of the disease , 2004, Gastric Cancer.
[6] A. Ohtsu,et al. Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer , 2003, British Journal of Cancer.
[7] N. Koide,et al. Small Cell Carcinoma of the Esophagus with Reference to Alternating Multiagent Chemotherapy: Report of Two Cases , 2003, Surgery Today.
[8] K. Mori,et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. , 2002, The New England journal of medicine.
[9] Y. Maehara,et al. An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers , 1999, Oncology.
[10] A. Miwa,et al. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. , 1998, Archives of pathology & laboratory medicine.
[11] K. Arai,et al. Gastric small-cell carcinoma in Japan: a case report and review of the literature. , 1998, American journal of clinical oncology.
[12] M. Fukushima,et al. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. , 1996, Anti-cancer drugs.
[13] 胃癌研究会. Japanese classification of gastric carcinoma , 1995 .
[14] K. Pang,et al. Small cell carcinoma of the stomach. Case report. , 1994, Clinical imaging.
[15] C. Roberts,et al. Primary small-cell carcinoma of the stomach. , 1994, Oncology reports.
[16] A. Miwa,et al. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. , 1991, The American journal of gastroenterology.
[17] T. Splinter,et al. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas , 1990, Cancer.
[18] H. Hayakawa,et al. Oat cell carcinoma of the stomach. , 1980, Pathology, research and practice.